UNSPSC 51283952: Sulfarsphenamine

This classification denotes a topical anti-infective agent with the molecular formula C14H14As2N2O8S2.2Na, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier B1GGH4ZUZL, chemically known as 3,3-diamino-4,4-dihydroxyarsenobenzol-n,n-methanesulfonsaeure dinatrium salz but more generally known as sulfarsphenamine, which bears U.S. National Institutes of Health Compound Identifier 71510. The European Medicines Agency schedules Sulfarsphenamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10726MIG.

The term SULFARSPHENAMINE is an International Non-Proprietary Name. SULFARSPHENAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: [ASH](=[ASH]\C1CC(NCS(=O)(=O)O)C(O)CC1)/C1CC(NCS(=O)(=O)O)C(O)CC1.[NA].[NA].

UNSPSC 51283952 Sulfarsphenamine is a Commodity code that tracks procurement of this specific pharmaceutical ingredient, yet recent state and local activity under the code shows little alignment with the nominal scope. The two most recent opportunities posted under this code—an Illinois Department of Public Health pharmaceutical warehouse piggyback award and a Seminole County, Florida procurement—both involve finished-dose pharmaceuticals (Doxycycline Hyclate, Ciprofloxacin Hydrochloride, and Naloxone) rather than sulfarsphenamine as a raw ingredient or active pharmaceutical component. State and local procurement offices appear to be using this code inconsistently, or sulfarsphenamine itself may not be actively solicited as a standalone line item in current state and local supply chains.

The geographic activity shown is limited to Illinois and Florida, with no evidence of broader multistate procurement patterns under this code. The Illinois Department of Public Health executed a $2,999,999.11 piggyback contract through the MMCAP Infuse cooperative purchasing vehicle to Chartwell Rx LLC, completed on August 28, 2026, as a 12-month initial term with two renewal options; this was an IFB award process with no set-aside requirements. Seminole County posted an IFB on June 30, 2026, for Naloxone and drug deactivation systems with a July 26, 2023 response deadline, but this opportunity predates the current solicitation cycle and may reflect an outdated posting. Neither opportunity directly solicits sulfarsphenamine, and the code appears underutilized or misapplied in current state and local procurement practice.